Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MYRIAD GENETICS INCMYGN · Entity 5953 | Exec. VP International Ops | September 30, 2019 | October 02, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MYRIAD GENETICS INC
Report date September 30, 2019 · Filed October 02, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 148,397 |
Ending reported balance
After 2019-09-30 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-09-30 · Disposition to issuer · Disposed 3,826 · Balance 151,724 F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Row 2 · 2019-09-30 · Disposition to issuer · Disposed 3,327 · Balance 148,397 F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2019 Filed Oct 2, 2019 01:02 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 3,327 | $28.63 | $95,252.01 |
DisclosureSEC source: 0000899243-19-024543 · doc4.xml · nonDerivative · entry 2 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,397 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 01:02 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 3,826 | $28.63 | $109,538.38 |
DisclosureSEC source: 0000899243-19-024543 · doc4.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,724 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 25, 2019 Filed Sep 26, 2019 21:01 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 27,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001495800-19-000004 · edgardoc.xml · nonDerivative · entry 3 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,550 F2 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 26, 2020, 25% on September 26, 2021, 25% on September 26, 2022, and 25% on September 26, 2023. Read SEC document |
| September 25, 2019 Filed Sep 26, 2019 21:01 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 3,327 | $29.93 | $99,577.11 |
DisclosureSEC source: 0001495800-19-000004 · edgardoc.xml · nonDerivative · entry 2 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,550 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 25, 2019 Filed Sep 26, 2019 21:01 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 2,994 | $29.93 | $89,610.42 |
DisclosureSEC source: 0001495800-19-000004 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,877 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 20:44 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $26.49 | $0.00 |
DisclosureSEC source: 0001495800-19-000002 · edgardoc.xml · derivative · entry 9 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,225 Underlying: Common Stock · 30,000 shares Expires 2021-09-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 20:44 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $23.98 | $0.00 |
DisclosureSEC source: 0001495800-19-000002 · edgardoc.xml · derivative · entry 8 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,830 Underlying: Common Stock · 10,000 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 20:44 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $19.47 | $0.00 |
DisclosureSEC source: 0001495800-19-000002 · edgardoc.xml · derivative · entry 7 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,432 Underlying: Common Stock · 20,000 shares Expires 2021-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 20:44 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | SaleCommon Stock | 20,000 | $39.44 | $788,810.00 |
DisclosureSEC source: 0001495800-19-000002 · edgardoc.xml · nonDerivative · entry 6 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,871 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 20:44 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionCommon Stock | 20,000 | $19.47 | $389,400.00 |
DisclosureSEC source: 0001495800-19-000002 · edgardoc.xml · nonDerivative · entry 5 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 20:44 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | SaleCommon Stock | 10,000 | $43.48 | $434,816.00 |
DisclosureSEC source: 0001495800-19-000002 · edgardoc.xml · nonDerivative · entry 4 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,871 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 20:44 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionCommon Stock | 10,000 | $23.98 | $239,800.00 |
DisclosureSEC source: 0001495800-19-000002 · edgardoc.xml · nonDerivative · entry 3 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 20:44 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | SaleCommon Stock | 30,000 | $46.19 | $1,385,703.00 |
DisclosureSEC source: 0001495800-19-000002 · edgardoc.xml · nonDerivative · entry 2 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,871 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 20:44 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionCommon Stock | 30,000 | $26.49 | $794,700.00 |
DisclosureSEC source: 0001495800-19-000002 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 13:13 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 3,327 | $46.00 | $153,042.00 |
DisclosureSEC source: 0001495800-18-000012 · edgardoc.xml · nonDerivative · entry 2 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,973 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 13:13 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 3,826 | $46.00 | $175,996.00 |
DisclosureSEC source: 0001495800-18-000012 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,300 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 18:30 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 3,327 | $46.65 | $155,204.55 |
DisclosureSEC source: 0001495800-18-000010 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,126 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 16:22 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 27,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001495800-18-000008 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,453 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 25, 2019, 25% on September 25, 2020, 25% on September 25, 2021, and 25% on September 25, 2022. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 18:35 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 5,101 | $46.35 | $236,431.35 |
DisclosureSEC source: 0001495800-18-000006 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,453 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| January 22, 2018 Filed Jan 22, 2018 23:16 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $19.47 | $0.00 |
DisclosureSEC source: 0001495800-18-000004 · edgardoc.xml · derivative · entry 6 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,432 Underlying: Common Stock · 30,000 shares Expires 2021-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations. Read SEC document |
| January 22, 2018 Filed Jan 22, 2018 23:16 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,445 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001495800-18-000004 · edgardoc.xml · derivative · entry 5 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,445 shares Expires 2021-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations. Read SEC document |
| January 22, 2018 Filed Jan 22, 2018 23:16 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | SaleCommon Stock | 4,445 | $39.03 | $173,488.35 |
DisclosureSEC source: 0001495800-18-000004 · edgardoc.xml · nonDerivative · entry 4 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,968 Read SEC document |
| January 22, 2018 Filed Jan 22, 2018 23:16 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionCommon Stock | 4,445 | $18.00 | $80,010.00 |
DisclosureSEC source: 0001495800-18-000004 · edgardoc.xml · nonDerivative · entry 3 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,413 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2018 Filed Jan 22, 2018 23:16 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | SaleCommon Stock | 30,000 | $39.77 | $1,193,100.00 |
DisclosureSEC source: 0001495800-18-000004 · edgardoc.xml · nonDerivative · entry 2 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,968 Read SEC document |
| January 22, 2018 Filed Jan 22, 2018 23:16 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionCommon Stock | 30,000 | $19.47 | $584,100.00 |
DisclosureSEC source: 0001495800-18-000004 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 18, 2018 Filed Jan 19, 2018 19:21 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,120 | $0.00 Strike: $14.88 | $0.00 |
DisclosureSEC source: 0001495800-18-000002 · edgardoc.xml · derivative · entry 3 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,120 shares Expires 2020-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations. Read SEC document |
| January 18, 2018 Filed Jan 19, 2018 19:21 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | SaleCommon Stock | 3,120 | $38.12 | $118,934.40 |
DisclosureSEC source: 0001495800-18-000002 · edgardoc.xml · nonDerivative · entry 2 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,968 Read SEC document |
| January 18, 2018 Filed Jan 19, 2018 19:21 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionCommon Stock | 3,120 | $14.88 | $46,425.60 |
DisclosureSEC source: 0001495800-18-000002 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 21:17 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 3,522 | $36.18 | $127,425.96 |
DisclosureSEC source: 0001495800-17-000006 · edgardoc.xml · nonDerivative · entry 2 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,917 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 21:17 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 4,050 | $36.18 | $146,529.00 |
DisclosureSEC source: 0001495800-17-000006 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,439 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 17, 2017 Filed Sep 19, 2017 21:50 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 5,400 | $33.05 | $178,470.00 |
DisclosureSEC source: 0001495800-17-000004 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,489 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 21:05 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001495800-17-000002 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,889 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 21:46 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 4,050 | $20.58 | $83,349.00 |
DisclosureSEC source: 0001495800-16-000022 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,449 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 17, 2016 Filed Sep 20, 2016 12:56 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 3,721 | $20.92 | $77,843.32 |
DisclosureSEC source: 0001495800-16-000020 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,499 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 18:00 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001495800-16-000018 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,220 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.